Key Takeaways
- RBC Capital increased Astera Labs (ALAB) price target from $225 to $250 while maintaining Outperform rating
- Scorpio-X switch revenue tied to Trainium3 deployments expected to begin in Q3 2026 drives bullish outlook
- RBC forecasts Scorpio switch revenue expansion from $130M in 2025 to $390M in 2026
- UBS launched coverage with Neutral rating and $180 target, highlighting competitive pressures in switching segment
- Q4 2025 results showed ALAB delivered $0.58 EPS, surpassing $0.51 consensus, with revenue climbing 92% YoY to $270.6M
Astera Labs experienced a whirlwind Monday as two separate analyst firms weighed in on the stock — offering contrasting perspectives that highlighted both opportunity and caution.
Astera Labs, Inc. Common Stock, ALAB
RBC Capital Markets elevated its price objective for Astera Labs from $225 to $250 while reaffirming its Outperform stance. Shares were changing hands near $175.80 during trading hours, marking approximately 10% gains for the session.
The optimistic outlook from RBC hinges on Scorpio-X, Astera’s upcoming advanced switch offering. Analysts anticipate Trainium3-linked Scorpio-X deployment revenues will materialize starting in the third quarter of 2026, creating additional revenue opportunities per processing unit.
RBC’s financial model shows total Scorpio switch revenues escalating from $130 million in 2025 to $390 million in 2026 — representing a threefold increase within twelve months.
The revised $250 price objective applies a 74x multiple to RBC’s calendar 2027 earnings per share forecast of $3.37. The previous valuation employed a 67x multiple. RBC justified the elevated multiple by citing several new product launches, substantial addressable market opportunities, anticipated revenue expansion of 40–50%, and gross profit margins exceeding 70%.
Astera’s current gross margin stands at 75.69%, with revenue expanding 115% over the trailing twelve-month period.
UBS Adopts Cautious Stance
UBS initiated coverage on ALAB the same Monday, establishing a Neutral rating with a $180 price target — barely exceeding the stock’s current trading level.
Analyst Natalia Winkler recognized the company’s credible five-year track record in AI networking infrastructure, highlighting solid execution in retimers and expanding partnerships beyond its primary customer, AWS. Astera introduced its retimer product line in 2019 and has subsequently grown its footprint across multiple hyperscale customers.
UBS forecasts 2027 revenues 4% above Street consensus, powered by retimers and the PCIe/UA Link switching product lineup. However, the firm’s 2028 projection sits 3% below consensus, pointing to intensifying competition in the switching market as a challenge.
Valuation concerns represent UBS’s primary hesitation. Astera commands a high-40s 2027 price-to-earnings ratio, significantly exceeding AI networking sector comparables. The firm indicated more attractive risk-reward profiles exist elsewhere within the networking industry.
Recent Quarterly Performance Supports Growth Narrative
Both analyst perspectives are informed by robust recent financial results. Astera disclosed Q4 2025 earnings per share of $0.58, exceeding the $0.51 Street estimate by roughly 14%.
Quarterly revenue reached $270.6 million, representing 92% year-over-year growth.
Twelve analysts have adjusted their earnings projections upward for the forthcoming period, based on InvestingPro intelligence.
The equity has delivered 223% returns over the past year. Despite this substantial appreciation, ALAB’s PEG ratio of 0.47 indicates valuation may remain reasonable relative to growth prospects — even with the headline P/E of 143 appearing elevated.
RBC’s $250 target represents approximately 42% upside potential from present levels. UBS’s $180 objective provides minimal appreciation opportunity from the current price point.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
